JCR Pharmaceuticals Revenue

JCR Pharmaceuticals had revenue of 8.51B JPY in the quarter ending September 30, 2024, a decrease of -36.78%. This brings the company's revenue in the last twelve months to 35.26B, down -18.07% year-over-year. In the fiscal year ending March 31, 2024, JCR Pharmaceuticals had annual revenue of 42.87B with 24.83% growth.

Revenue (ttm)

35.26B

Revenue Growth

-18.07%

P/S Ratio

2.07

Revenue / Employee

37.75M

Employees

934

Market Cap

71.27B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	42.87B	8.53B	24.83%
Mar 31, 2023	34.34B	-16.74B	-32.77%
Mar 31, 2022	51.08B	21.00B	69.79%
Mar 31, 2021	30.09B	5.30B	21.40%
Mar 31, 2020	24.78B	1.62B	7.00%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,142.35B
Daiichi Sankyo Company	1,758.07B
HOYA Corporation	812.74B
Takeda Pharmaceutical Company	4,546.08B
Otsuka Holdings	2,269.56B
Terumo	986.67B
Astellas Pharma	1,772.16B
Olympus	973.60B

Revenue Rankings